Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 111 citing Jasmer: Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis.... (0.13 sec) 

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and …


MA Gardam, EC Keystone, R Menzies, S … - The Lancet infectious diseases, 2003 - Elsevier
Cases of active tuberculosis have been reported worldwide with the use of
therapeutic agents that inhibit tumour necrosis factor (TNF) α. TNFα has a
central role in mycobacterial infection and disease. Accordingly, ...
Cited by 368 - Related articles - All 7 versions

Global drug-resistance patterns and the management of latent tuberculosis infection in …

- wnysmart.org [PDF] 
K Khan, P Muennig, M Behta, JG Zivin - The New England journal of medicine, 2002 - nejm.highwire.org
Page 1. Special Article 1850 · N Engl J Med, Vol. 347, No. 23 · December
5, 2002 · www.nejm.org The New England Journal of Medicine ...
Cited by 123 - Related articles - BL Direct - All 12 versions

A review of the application of propensity score methods yielded increasing use, advantages …

- nih.gov
T Stürmer, M Joshi, RJ Glynn, J Avorn, KJ … - Journal of clinical epidemiology, 2006 - Elsevier
Use of propensity scores increased from a total of 8 reports before 1998 to 71
in 2003. Most of the 177 published studies abstracted assessed medications (N =
60) or surgical interventions (N = 51), mainly in cardiology and cardiac ...
Cited by 98 - Related articles - All 24 versions

Latent tuberculosis infection

- jasoncartermd.com [PDF] 
RM Jasmer, P Nahid, PC Hopewell - New England Journal of Medicine, 2002 - content.nejm.org
Patient 1, a 44-year-old man who recently immigrated from Peru, is found to have
induration of 16 mm in diameter on a tuberculin skin test. He received bacille
Calmette–Guérin (BCG) vaccine as an infant and is asymptomatic. Chest ...
Cited by 95 - Related articles - BL Direct - All 8 versions

Update on the treatment of tuberculosis and latent tuberculosis infection

- wustl.edu [PDF] 
HM Blumberg, MK Leonard Jr, RM Jasmer - Jama, 2005 - Am Med Assoc
Tuberculosis (TB) has emerged as a global public health epidemic. Despite
decreasing numbers of cases in the United States since 1992, TB remains a
serious public health problem among certain patient populations and is ...
Cited by 89 - Related articles - All 12 versions

Use of isoniazid for latent tuberculosis infection in a public health clinic

- 171.66.122.149
PA LoBue, KS Moser - American journal of respiratory and critical care …, 2003 - 171.66.122.149
Isoniazid is an efficacious treatment for latent tuberculosis. Concerns remain,
however, regarding hepatotoxicity associated with this medication. In addition,
adherence may be suboptimal because at least 6 months of treatment is ...
Cited by 79 - Related articles - BL Direct - All 8 versions

An official ATS statement: hepatotoxicity of antituberculosis therapy


JJ Saukkonen, DL Cohn, RM Jasmer, S … - American journal of respiratory and critical care …, 2006 - Am Thoracic Soc
Drug-induced liver injury (DILI) is a problem of increasing significance, but
has been a long-standing concern in the treatment of tuberculosis (TB)
infection. The liver has a central role in drug metabolism and ...
Cited by 68 - Related articles - BL Direct - All 9 versions

Isoniazid Hepatotoxicity Associated With Treatment of Latent Tuberculosis Infection*

- Free from Publisher
FF Fountain, E Tolley, CR Chrisman, TH Self - Chest, 2005 - chestjournal.chestpubs.org
Results: Among 3,377 patients started on INH therapy, 19 patients had AST levels
more than five times the ULN, or a rate of 5.6 per 1,000 patients. Only 1 of 19
patients had prodromal symptoms associated with hepatotoxicity. After 1 ...
Cited by 51 - Related articles - BL Direct - All 6 versions

Treatment completion and costs of a randomized trial of rifampin for 4 months versus …

- 171.66.122.149
D Menzies, MJ Dion, B Rabinovitch, S Mannix … - American journal of respiratory and critical care …, 2004 - 171.66.122.149
There is little published information regarding treatment completion, safety,
and efficacy of rifampin administered daily for 4 months—a recommended
alternative to 9 months of isoniazid for therapy of latent tuberculosis ...
Cited by 39 - Related articles - BL Direct - All 6 versions

Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection …

- idsociety.org [PDF] 
FM Gordin, DL Cohn, JP Matts, RE Chaisson, … - Clinical Infectious Diseases, 2004 - UChicago Press
Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ...
Cited by 38 - Related articles - BL Direct - All 14 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google